FDA Investigator Gary J Lehr

Gary J Lehr has conducted inspections on 32 sites in 1 countries as of 21 Oct 2009. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
32
Last Inspection Date:
21 Oct 2009
Investigator Role:
FDA Investigator
Redica ID:
100006947
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Gary J Lehr:
Alice S Tsao, Althea A Williams, Amatul H Marium, Amy Wyan Mai, Andrew M Abramowitz, Ann M Stewart, Avital A Shimanovich, Bijoy Panicker, Brandy N Lepage, Brenda W Uratani, PhD, Charanjeet Jassal, Charisse K Green, Daniel L Zheng, David R Delucia, Demitria J Xiradakis, Dennis E Guilfoyle, PhD, Dongping Dai, PhD, Dr. Robert C Horan, MD, Edmund F Mrak, Jr, Edouard Viard, Felix Maldonado, Frank Verni, Gam S Zamil, Gary T Greco, Guerlain Ulysse, Helen B Ricalde, Irina Gaberman, J'maica J Hunter, Jaison J Eapen, James A Liubicich, Jay T Wong, Jazmine N Brown, Jazmine N Still, Jose Ohernandez Guzman, Joy P Matthias, Juan Rjimenez Garcia, Juanita P Versace, Justin A Boyd, Karen L Kosar, Karishma G Gopaul, Kazi Rafiquzzaman, Kenneth H Williams, Kevin A Gonzalez, Kim Lthomas Cruse, Kimberly Y Smithson, Krishna Ghosh, PhD, Lawrence W Farina, Marie B Buen Bigornia, Michael A Charles, Michael Levin, Mindy M Chou, Nariman Patenaude, Nazmul Hassan, Neil J Bonzagni, PhD MPH, Nerizza B Guerin, Nicholas A Violand, Omadevi Somai, Investigator, Parul M Patel, Patrick C Klotzbuecher, Paul Mouris, Peter Abel, Peter Caparelli, Peter R Caparelli, Philip F Istafanos, DMV, MS, Rachael A Moliver, Raihan A Chowdhury, Ramon A Hernandez, Robert C Steyert, Rochelle K Kimmel, Samina S Khan, Sarah A Meehan, Sarah A Wangseng, Satheesh Thomas, Shari L Kahn, Simone E Pitts, Sony Mathews, Steven M Weinman, Susan M Joseph, Susan T Hadman, Susan W Ting, Suwaskie S Smith, Tanya R Syffrard, Terry Bridgewater, Thomas J Arista, Thomas J Mooney, Tracy M Portelli, Uduak M Inokon, Valentino Fiorella, Valerie A Potopsingh, Vioela J Caze, Xiaokuang Lai, PhD

Gary J Lehr's Documents

Publish Date Document Type Title
November, 2002 FDA 483 Intermax Pharmaceuticals, Inc. - Form 483, 2002-11-20
February, 2005 FDA 483 Syntho Pharmaceuticals Inc. - Form 483, 2005-02-04
April, 2008 FDA 483 Citigroup Biomedical Imaging Center - Form 483, 2008-04-17
June, 2005 FDA 483 American Regent, Inc. - Form 483, 2005-06-27
February, 2005 FDA 483 Response Syntho Pharmaceuticals Inc. - Form 483R, 2005-02-23
April, 2009 FDA 483 Corwood Labs Inc - Form 483, 2009-04-08
June, 2009 FDA 483 TIME CAP LABORATORIES, INC - Form 483, 2009-06-29
February, 2009 FDA 483 Syntho Pharmaceuticals Inc. - Form 483, 2009-02-03
March, 2002 FDA 483 Chartwell Pharmaceuticals Amityville, LLC. - Form 483, 2002-03-13
October, 2003 FDA 483 Syntho Pharmaceuticals Inc. - Form 483, 2003-10-17
April, 2009 FDA 483 Altaire Pharmaceuticals Inc. - Form 483, 2009-04-28
June, 2009 EIR TIME CAP LABORATORIES, INC - EIR, 2009-06-29
November, 2002 FDA 483 Syntho Pharmaceuticals Inc. - Form 483, 2002-11-20
August, 2006 FDA 483 Altaire Pharmaceuticals Inc. - Form 483, 2006-08-10
November, 2006 FDA 483 Fougera Pharmaceuticals Inc. - Form 483, 2006-11-09
July, 2008 FDA 483 Altaire Pharmaceuticals Inc. - Form 483, 2008-07-02
June, 2006 FDA 483 Inwood Labs - Form 483, 2006-06-16
December, 2008 EIR TIME CAP LABORATORIES, INC - EIR, 2008-12-05
March, 2002 FDA 483 Response Chartwell Pharmaceuticals Amityville, LLC. - Form 483R, 2002-03-26
March, 2008 FDA 483 The Feinstein Institutes for Medical Research - Form 483, 2008-03-25
January, 2000 EIR Jerome Stevens Pharmaceuticals, Inc. - EIR, 2000-01-27
December, 2008 FDA 483 TIME CAP LABORATORIES, INC - Form 483, 2008-12-05
January, 2000 FDA 483 Jerome Stevens Pharmaceuticals, Inc. - Form 483, 2000-01-27
June, 2005 EIR American Regent, Inc. - EIR, 2005-06-27
June, 2005 FDA 483 Response American Regent, Inc. - Form 483R, 2005-07-06
December, 2009 FDA 483 Chartwell Pharmaceuticals Amityville, LLC. - Form 483, 2009-12-03
March, 2002 EIR Chartwell Pharmaceuticals Amityville, LLC. - EIR, 2002-03-13

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more